bepmed |

2008050753
l 2008
US

4001. Ceramidase gene

Abstract

A neutral/alkaline ceramidase derived from a mammal; an antibody specifically binding thereto; a probe and primer which are capable of specifically hybridizing thereto; a method...

13:53 / cells / methods

2008014181
l 2008
US

4002. Cell separation apparatus and methods of use

Abstract

The present invention provides automated devices for use in supporting various cell therapies and tissue engineering methods. The present invention provides an automated cell separation...

13:53 / cells / methods

2008119848
l 2008
US

4003. Selectively absorbable/biodegradable, fibrous composite constructs and applications thereof

Abstract

A family of selectively absorbable/biodegradable, fibrous composite constructs includes different combinations of biostable and absorbable/biodegradable yarns assembled as initially interdependent, load-bearing components, transitioning to exhibit...

13:53 / methods / Scaffolds

2008154022
l 2008
US

4004. Transport of basic fibroblast growth factor across the blood brain barrier

Abstract

Compositions and methods for increasing the receptor mediated transport of basic fibroblast growth factor (bFGF) across the blood brain barrier (BBB). The bFGF is conjugated...

13:53 / growth factors / methods

2008194023
l 2008
US

4005. Generating vascular smooth muscle cells in vitro from ES cells

Abstract

A simplified and inexpensive method for the in-vitro identification, isolation and culture of human vasculogenic progenitor cells is provided. The method and the progenitor cells...

13:53 / cells / methods

2008061014
l 2008
WO

4006. SELF-ASSEMBLING PEPTIDE AMPHIPHILES FOR TISSUE ENGINEERING

Abstract

The present invention provides for compositions and methods for creating self-assembled peptide amphiphile (PA) structures. In particular, the present invention provides for two and three-dimensional...

13:53 / methods / Scaffolds

2008095820
l 2008
US

4007. Method of manufacturing hydroxyapatite and uses therefor in delivery of nucleic acids

Abstract

Provided is a method for production of nanocrystalline hydroxyapatite particles, and nanocrystalline hydroxyapatite particles produced according to the method. The nanocrystalline hydroxyapatite particles exhibit substantially...

13:53 / Biomaterial / methods

101249277
l 2008
CN

4008. Three-dimensional stephanoporate organization engineering bracket material, fibre cementing method preparing same and applications thereof

Abstract

The invention relates to a three-dimensional porous tissue engineering stent material, a fiber-gluing preparation method thereof and the application thereof, The material comprises poly butylene...

13:53 / rest

2008126092
l 2008
WO

4009. COMPOSITIONS AND METHODS FOR SCAFFOLD FORMATION

Abstract

The present invention relates to scaffolds composed of a protein backbone cross-linked by a synthetic polymer. Specifically, the present invention provides PEGylated-thiolated collagen scaffolds and...

13:53 / methods / Scaffolds

101288779
l 2008
CN

4010. Syringeability cardiac muscle tissue engineering products based on thermo-sensitive chitosan hydrogel

Abstract

The invention discloses an injective myocardial tissue engineering product basing on temperature responsive chitosan hydrogel and more particularly relates to liquid temperature responsive chitosan hydrogel...

13:53 / cells / methods

Author: admin

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract